You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 95 No. 5, May 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Tryptophan Metabolism

A Hitherto Unreported Abnormality Occurring in a Family

J. M. Price, MD, PhD; Norma Yess, MS; R. R. Brown, PhD; Sture A. M. Johnson, MD

Arch Dermatol. 1967;95(5):462-472.


Abstract

A young girl with scleroderma and 21 members of her family were studied for their ability to metabolize tryptophan by the pathway which leads to nicotinic acid. Nine of ten female members of the family and two of 12 males had abnormal tryptophan metabolism.

The metabolic disorder was characterized by a pattern of urinary tryptophan metabolities in which kynurenine was the major excretory product of the tryptophan-nicotinic acid pathway, with one or more of the following metabolites present in greater than normal quantities: o-aminohippuric acid, kynurenic acid, or acetylkynurenine. This metabolic disorder differs from hydroxykynureninuria by the pattern of urinary tryptophan metabolites, and from the hereditary disorder of tryptophan metabolism described by Knapp by the pattern of urinary tryptophan metabolites and the response of that condition to the administration of pyridoxine.



Author Affiliations

Madison, Wis

From the Division of Clinical Oncology (Drs. Price and Brown and Miss Yess) and the Department of Dermatology and Syphilology (Dr. Johnson), University of Wisconsin Medical School. Miss Yess is presently at the Department of Nutrition, School of Public Health, Harvard University, Boston.


Footnotes

Accepted for publication Jan 31, 1967.

Read before the annual meeting of the American Dermatological Association, April 1966, White Sulfur Springs, Va.

Reprint requests to 1300 University Ave, Madison, Wis 53706 (Dr. Price).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Idiopathic and L-Tryptophan-Associated Eosinophilic Fasciitis Before and After L-Tryptophan Contamination
Blauvelt and Falanga
Arch Dermatol 1991;127:1159-1166.
ABSTRACT  

Eosinophilic Fasciitis Associated With Tryptophan Ingestion: A Manifestation of Eosinophilia-Myalgia Syndrome
Gordon et al.
Arch Dermatol 1991;127:217-220.
ABSTRACT  

Scleroderma-like Lesions and the Carcinoid Syndrome
Fries et al.
Arch Intern Med 1973;131:550-553.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.